Sanuwave Health (SNWV): Chief Operating Officer sold ~$52K

~$52K

Approx. value · 1,862 sh @ $27.71

2,032

Holds after · shares reported

Traded

Jun 5, 2025

Filed

Jun 9, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Apr 29, 2025Insider · 1 personInsiders: 2 purchases (~$204K)
2. May 15, 2025InsiderOfficer sold ~$115K of SNWV shares in the open market
3. Jun 5, 2025 · this disclosureInsiderOfficer sold ~$52K of SNWV shares in the open market

What came next

1. Sep 25, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
2. Sep 25, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 25, 2025, Daniel Coyle was appointed the Chief Operating Officer of Sanuwave Health, Inc. (the “Company”). Mr. Coyle, age 35, was the Company’s Vice President of Engineering and Operations from October 2024 through September 2025, and a Program Director at Nextern, a medical device manufacturer, from September 2019 through September 2024.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Sanuwave Health

For Sanuwave Health, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SNWV page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Sanuwave Health

• SEC Schedule 13GNov 13, 2026
• SEC Form 4May 4, 2026
• SEC Form 4May 4, 2026
• SEC Form 4May 4, 2026
• SEC Form 4May 4, 2026
• SEC Form 4Apr 30, 2026

Everything OQRO holds on this company is on its SNWV page.